Author

G. Almanza

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Organism:mouse· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1

Frequent Co-Authors

M. Zanetti· 2 shared A. Castro· 1 shared A. E. Clark· 1 shared A. F. Carlin· 1 shared A. Lew· 1 shared A. Salm· 1 shared A. T. Batista· 1 shared E. Ollmann Saphire· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

M. Zanetti

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Structure selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern

G. Almanza, V. Kouznetsova, A. E. Clark, E. Olmedillas, A. Castro, I. F. Tsigelny, Y. Wu, G. F. Gao, E. Ollmann Saphire, A. F. Carlin, M. Zanetti

This study shows that structure-selected RBM immunogens induce polyclonal memory responses that neutralize SARS-CoV-2 variants of concern.

PLOS Pathogens · Jul 21, 2022Peer-reviewedImmunology

IRE1? regulates macrophage polarization, PD-L1 expression and tumor survival

M. Zanetti, A. T. Batista, J. Rodvold, S. Xian, S. T. Searles, A. Lew, T. Iwawaki, G. Almanza, T. C. Weller, J. Lin, K. Jepsen, H. Carter

This study shows that IRE1 regulates macrophage polarization, PD-L1 expression, and tumor survival in mice and humans.

bioRxiv · Feb 17, 2020Cancer Biology

Phylobioactive hotspots identified through multidimensional profiling of botanical drugs used to treat Chagas disease in Bolivia and Dioscorides' De Materia Medica

A. Salm, S. R. Krishnan, M. Collu, O. Danton, M. Hamburger, M. Leonti, G. Almanza, J. Gertsch

This study compares botanical drugs used for Chagas disease in Bolivia with those from Dioscorides' De Materia Medica to identify phylobioactive hotspots and assess their antitrypanosomal activity.

bioRxiv · Dec 2, 2019 · PreprintPharmacology & Toxicology